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Background: The major complications of “treated” Human Immunodeﬁciency Virus (HIV)
infection are cardiovascular disease, malignancy, renal disease, liver disease, bone disease,
and  perhaps neurological complications, which are phenomena of the normal aging pro-
cess  occurring at an earlier age in the HIV-infected population. The present study is aimed
to  explore protein carbonyl content as a biomarker for detecting oxidative DNA damage
induced ART toxicity and/or accelerated aging in HIV/AIDS patients.
Objective: To investigate the potential of carbonyl content as a biomarker for detecting oxida-
tive  Deoxyribonucleic acid (DNA) damage induced Antiretroviral Theraphy (ART) toxicity
and/or accelerated aging in HIV/AIDS patients.
Methods: In this case–control study a total 600 subjects were included. All subjects were ran-
domly selected and grouped as HIV-negative (control group) (n = 300), HIV-infected ART naive
(n  = 100), HIV-infected on ﬁrst line ART (n = 100), and HIV-infected on second line ART (n = 100).
Seronegative control subjects were age- and sex-matched with the ART naive patients and
the  two other groups. Carbonyl protein was determined by the method described in Levine
et  al. DNA damage marker 8-OH-dG was determined using 8-hydroxy-2-deoxy Guanosine
StressXpress ELA Kit by StressMarq Biosciences.
Results: Protein carbonyl content levels and oxidative DNA damage were signiﬁcantly higher
(p  < 0.05) in HIV-infected patients on second line ART and HIV-infected patients on ﬁrst line
ART  than ART naive patients and controls. In a linear regression analysis, increased protein
carbonyl content was positively associated with increased DNA damage (OR: 0.356; 95% CI:
0.287–0.426) p < 0.05.
Conclusions: Carbonyl content may has a role as a biomarker for detecting oxidative DNA
damage induced ART toxicity and/or accelerated aging in HIV/AIDS patients. Larger studies
are  warranted to elucidate the role of carbonyl content as a biomarker for premature agingin  HIV/AIDS patients.Please cite this article in press as: Kolgiri V, Patil VW. Protein carbonyl con
Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.007
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Introduction
The AIDS epidemic continues to spread in the South-East
Asia (SEA) Region. The South-East Asia is the second most
affected WHO  region in the world, after sub-Saharan Africa.
To date, close to 40 million people throughout the world have
been infected with human immunodeﬁciency virus (HIV). Of
these, almost 6.4 million are in the SEA Region. Over 99%
of cases have been reported from four countries – Thailand,
India, Indonesia and Myanmar.1 More  than 25 antiretrovi-
ral drugs from six therapeutic classes are now available for
the management of HIV infection. Most patients who take
medication achieve durable and perhaps lifelong viral sup-
pression, so the classic AIDS related conditions are becoming
less common. However, treated patients do not have com-
pletely restored health. Compared with people without HIV
infection, patients with the infection who are treated with
antiretrovirals have increased risk for several “non-AIDS”
complications, many  of which are commonly associated with
aging.2
The major complications of “treated” HIV disease are car-
diovascular disease, malignancy, renal disease, liver disease,
bone disease, and perhaps neurological complications, which
are phenomena of the normal aging process, occur at an ear-
lier age in the HIV infected population.3
A critical research question is whether HIV is accelerating
aging itself through pathways and mechanisms common to
the aging process or, alternatively, HIV may simply be an addi-
tional risk factor for a wide number of chronic conditions thus
accentuating the prevalence of disease at every age. This situ-
ation is further complicated by concern that toxicities of ART,
not HIV itself, may contribute to aging and age-related illness.
Speciﬁc biomarkers of aging are limited in HIV-infected hosts
and impacted by antiretroviral therapy, and a high rate of mod-
iﬁable life style confounders (e.g., smoking, substance abuse,
alcohol) and co-infections (e.g., viral hepatitis) in HIV-infected
participants. There is a need for validated biomarkers of aging
in the context of HIV and ART.4–7
To show that HIV infection is associated with accelerated
normal aging, one ﬁrst needs to understand what is meant by
normal aging and to ﬁnd a way of measuring it.
Aging, also described as organismal senescence, is deﬁned
as a state with decreased ability to respond to stress, decreased
homeostatic balance, and an increased risk of developing age-
related diseases.8
Oxidative stress leads to an elevated oxidation of macro-
molecules, such as DNA, lipids, and proteins. It was
postulated that age-related accumulation of damaged, oxi-
dized, and aggregated proteins might contribute to the aging
process.8,9
Oxidation of proteins leads to a partial unfolding and,
therefore, to aggregation. Protein aggregates impair the
activity of cellular proteolytic systems (proteasomes, lyso-
somes), resulting in further accumulation of oxidized proteins.
In addition, the accumulation of highly cross linked pro-
tein aggregates leads to further oxidant formation, damagePlease cite this article in press as: Kolgiri V, Patil VW. Protein carbonyl con
Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.007
to macromolecules and ﬁnally, to apoptotic cell death.
Furthermore, protein oxidation seems to play a role in
the development of various age related diseases, such as 6;x x x(x x):xxx–xxx
neurodegenerative diseases, type 2 diabetes, cancer, and car-
diovascular disease.2
Two of the most commonly measured oxidative protein
modiﬁcations are protein carbonyls and 3-NT, which are
used to assess the cellular status of protein oxidation. Pro-
tein carbonyls are generated due to the oxidation of proline,
arginine, lysine, threonine, and other amino-acid residues
and due to the oxidation of the protein backbone. More-
over, they might be the result of secondary reactions of
amino acids (cysteine, histidine, and lysine) with reactive
carbonyl compounds (ketones, aldehydes), emerged in lipid
peroxidation or glycation/glycoxidation reactions.9 One way
to measure protein oxidation is to determine levels of protein
carbonyls.10
Under normal physiological conditions in all aerobic
organisms, there is a balance maintained between endoge-
nous oxidants and numerous enzymatic and non-enzymatic
antioxidant defences. When an imbalance occurs, oxidants
produce extensive oxidative damage to DNA, which, in turn,
contributes to aging, malignant tumors, and other degenera-
tive diseases.11,12 Oxidative injury is integral to HIV/AIDS as a
potent inducer of viral activation, viral replication, and DNA
damage in infected cells.13,14
Although many  damaged DNA lesions have been identi-
ﬁed, we have chosen 8-hydroxy-2-deoxyguanosine (8-OHdG)
as our biomarker of oxidative damage. The importance of
this lesion stems from the fact that it is both abundant
in DNA and it is mutagenic. Current evidence suggests
that 8-OHdG lesions present in DNA during cellular replica-
tion results in somatic mutation, the driving force behind
carcinogenesis.13,15 Determination and analysis of 8-OHdG
can be performed in animal organs and in human sample
(urine, human organs, leukocyte DNA) as a biomarker of oxida-
tive stress, aging, and carcinogenesis.16,17 Many  studies in the
past 20 years and improvements in the quantitative estima-
tion of 8-OHdG by various analytical techniques in blood cells
or in urine have established it as a very important biomarker
not only for carcinogenesis but also for aging and degenerative
diseases.18–21
The search of suitable biomarkers for aging in HIV/AIDS
patients is ongoing. There is need of biomarker for premature
aging that could alert the clinician to further investigate non
AIDS related diseases in HIV/AIDS patients. Such a tool should
be inexpensive and facilities for its determination easily
available.
In this study we determined protein oxidation marker car-
bonyl content and correlated it with DNA damage marker
8-OHdG in HIV-infected patients on ART, ART naïve, and HIV-
negative controls.
Methods
Subject  selection
A case–control study was carried out on HIV-1 infected
patients at the outpatient infectious disease unit (OPD) andtent: a novel biomarker for aging in HIV/AIDS patients. Braz J Infect
ART centre of the Sir J J Hospital & Grant Government Medi-
cal College, Mumbai over a period of one year, from February
2014 to March 2015. We have selected 300 subjects from
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PD after evaluation of their medical records (negative serial
LISA/Western blot test for HIV before three months of sam-
le collection) as HIV-negative controls and 300 HIV-infected
ubjects detected by serial ELISA/Western blot method from
RT centre. All subjects were randomly selected and grouped
s HIV-negative (control group) (n = 300), HIV-infected ART
aive (n = 100), HIV-infected on ﬁrst line ART (n = 100) and
IV-infected on second line ART (n = 100). Seronegative con-
rol subjects were age- and sex-matched with the ART naive
atients and the two other groups. We  used power analysis
ethod for sample selection at 5% signiﬁcance level for 95%
onﬁdence interval.
We do not have data regarding baseline viral load, CD4
adir, and viral suppression after starting ART for the study
opulation, as these are not included in routine tests for
IV/AIDS patients at ART centre of the Sir J J Hospital &Grant
overnment Medical College, Mumbai. As this was a self-
unded study we  could not perform these tests due to limited
unds.
thical  approval
he study protocol was approved by the institutional ethics
ommittee (No. IEC/Pharm/902/2013) and National AIDS Con-
rol Organization Delhi, India (T-11020/67/2011-NACO).
nclusion  criteria
ll participants were 20 years of age or older HIV-infected
atients detected by serial ELISA/Western blot method and
ere included in this study after giving their informed con-
ent. We  have selected 300 subjects from OPD after evaluation
f their medical records (negative serial ELISA/Western blot
est for HIV before three months of sample collection) as HIV-
egative controls (n = 300).
xclusion  criteria
xclusion criteria included pregnant women, patients with
hronic diseases like hepatitis, diabetes, renal impairment,
ardiovascular co-morbidities, neurological psychiatric dis-
rders, various malignancies, as well as heavy smokers,
lcoholics, tobacco-chewers, and HIV-infected patients with
ithdrawal of combination ART. The demographic details
ere collected from each patient and entered into the
ro-forma. Subsequent to this, a detailed history was
aken.
ample  collection
enous blood samples were collected in plain and lithiumPlease cite this article in press as: Kolgiri V, Patil VW. Protein carbonyl con
Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.007
eparin vacutainers as an anticoagulant. Blood was cen-
rifuged (4000 g, 10 min, 4 ◦C) to separate the plasma. The
ollected plasma was stored at −70 ◦C with aseptic precau-
ions. Plain blood samples 2 h after collection were centrifuged
t 3000 rpm for 5 min; serum was separated and collected in
terile tubes.;x  x x(x x):xxx–xxx 3
Different  treatment  regimens  as  per  NACO  guidelines
The list of antiretroviral therapy administered to Indian HIV-
infected patients was as follows:
First line therapy Second line therapy
Tenofovir Tenofovir
Lamivudine Lamivudine
Efavirenz Ritonavir
Atazanavir
Biochemical  methods
Determination  of  protein  carbonyl  content
Protein carbonyl proteins were assayed by 2,4-
dinitrophenylhydrazine reaction.22 The assay is based on
the spectrophotometric detection of the reaction between
2,4-dinitrophenyl hydrazine (DNPH) with protein carbonyl to
form protein hydrazone. Carbonyl content was determined as
nmol mg−1 protein. The total protein content was measured
using colorimetric kit based on biuret method.
Determination  of  DNA  damage  marker
8-hydroxy-2-deoxyguanosine  (8-OHdG)
Plasma of all the cases and control samples was used for
the measurement of 8-OHdG levels using competitive in vitro
Enzyme-Linked Immunosorbent Assay (ELISA) kit obtained
from StressXpress ELA Kit by StressMarq Biosciences. 8-OHdG
measurements were performed using microtiter ELISA plate
pre-coated with anti-mouse IgG. 50 L sample, 50 L 8-OHdG
AChE (acetylcholinesterase) tracer and 50 L 8-OHdG mono-
clonal antibody were added to each well and incubated at
4 ◦C for 18 h. After the wells were washed ﬁve times, 200 L
Ellman’s reagent was added to each well. The wells were
incubated at room temperature in the dark for 100 min. The
absorbance was read at wavelength of 420 nm.  ELISA assay
displays IC50 (50% B/B0) and IC80 (80% B/B0) values of approxi-
mately 100 and 30 pg mL−1, respectively.
Statistical  methods
Data were expressed as the mean ± SD. Student’s t test was
performed to assess differences between two means. Sta-
tistical analysis was performed using EPI-INFO 7 statistical
software for medical research studies. Differences in means
between groups were tested using independent-sample t-
tests. p < 0.05 was considered as statistically signiﬁcant.
Mann–Whitney test for non parametric continuous variables,
Chi-square or Fisher’s exact test for categorical variables were
used to test for statistical signiﬁcance. We used linear regres-
sion method for correlation of protein carbonyl content and
DNA damage marker 8-OH-Dg, and we used logistic regres-
sion method for comparison between two age groups and ART
second-line, ART ﬁrst-line, and ART naïve.tent: a novel biomarker for aging in HIV/AIDS patients. Braz J Infect
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Table 1 – Patients characteristics, CD4 count, plasma DNA damage marker 8-OHdG, and serum carbonyl content.
Group Subgroup Male/female Age (mean) CD4 (mean) Time on anti-retroviral
therapy (mean)
8-OHdG Carbonyl content
count years cells/L months ng/mL nmol/mg of protein
HIV-negative
controls
20–40  yrs 87/63 34.8 ± 5.1 NA NA 1.07 ± 0.25 0.64 ± 0.08
40–60 yrs 92/58 47.3 ± 5.4 NA NA 1.30 ± 0.32 0.66 ± 0.10
HIV-infected ART
naive
20–40  yrs 28/22 31.6 ± 4.2b 624 ± 202b NA 1.81 ± 0.66a 0.76 ± 0.13a
40–60 yrs 33/17 45.2 ± 6.1b 602 ± 134b NA 1.95 ± 0.56a 0.77 ± 0.18a
HIV-infected on
ﬁrst line ART
20–40  yrs 30/20 34.3 ± 5.2b 502 ± 233b 63.6a 2.50 ± 0.91a 1.06 ± 0.31a
40–60 yrs 41/9 48.3 ± 4.8b 465 ± 165b 65.7a 3.13 ± 0.92a 1.08 ± 0.37a
HIV-infected on
second line ART
20–40 yrs 36/14 35.6 ± 4.3b 400 ± 144b 74.3a 2.79 ± 0.95a 1.20 ± 0.36a
40–60 yrs 43/7 47.5 ± 5.3b 376 ± 183b 76.8a 3.27 ± 0.99a 1.22 ± 0.36a
Values are mean ± SEM of subjects. The data were analyzed by one-way ANOVA.
a p < 0.01 signiﬁcant when compared to control.
b p < 0.05 signiﬁcant when compared to control.
Results
A total of 600 (300 HIV-infected and 300 HIV negative) subjects
were included in this study. All the subjects were divided in
two age groups (20–40 yrs) and (40–60 yrs). As seen in Table 1,
the mean carbonyl content levels were signiﬁcantly higher
than that of the control group for the ART-naïve (p < 0.001)
group, those on ﬁrst-line ART (p < 0.001) and on second-line
ART (p < 0.001) in both age groups. DNA damage marker levels
were also signiﬁcantly higher than that of the control group
for the ART naïve (p = 0.001), those on ﬁrst-line ART (p < 0.001)
and on second-line ART (p < 0.001) in both age groups. Carbonyl
content and DNA damage marker levels correlated positively
with each other for the total patient sample (OR: 0.356; 95% CI:
0.287–0.426) [p < 0.001]. These results supported the notion of
carbonyl content as the better marker of inﬂammatory activ-
ity and are in agreement with the concept of ART toxicity as
a condition with increased inﬂammatory activity with DNA
damage.
Carbonyl content was signiﬁcantly higher in HIV-infected
patients on ART than HIV-infected ART naïve subjects and HIV
negative controls. The mean carbonyl content for HIV-infected
ART naive patients in age group 20–40 yrs was 0.76 nmol/mg
of protein and in age group 40–60 yrs was 0.74 nmol/mg of pro-
tein. The mean carbonyl content for HIV-infected in both age
groups, 20–40 yrs and 40–60 yrs on ART (ﬁrst line) were 1.06 and
1.21 nmol/mg of protein and 1.06 and 1.22 nmol/mg of protein
for those on second line.
We consider the normal value for carbonyl content is up to
0.75 nmol/mg of protein and more  than 0.75 nmol/mg of pro-
tein is considered as abnormal value of carbonyl content.22
Carbonyl content was abnormal in 14 (28%) ART naive HIV-
infected patients in the age group 20–40 yrs and in 17 (34%)
in the age group 40–60 yrs. The carbonyl content was signif-
icantly more  abnormal in HIV-infected patients in both age
groups (20–40 yrs and 40–60 yrs) on ART: 31 (62%) on ﬁrst line
and 33 (66%) on second line, and 35 (70%) and 38 (76%), respec-Please cite this article in press as: Kolgiri V, Patil VW. Protein carbonyl con
Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.007
tively. These results show that carbonyl content was increased
in HIV-infected patients on ART. In a logistic regression analy-
sis carbonyl content was signiﬁcantly different between the
age groups of 20–40 yrs and 40–60 yrs (OR: 0.609; 95% CI:0.4502–0.8258 – p < 0.001), between second-line and ﬁrst-line
ART (OR: 0.7959; 95% CI: 0.5183–1.222 – p < 0.296), and between
naïve patients and those on ﬁrst-line (OR: 5.717; 95% CI:
3.762–8.672 – p < 0.001). The mean 8-OH-DG for HIV-infected
patients was higher than that for HIV negative subjects. The
mean 8-OH-DG for HIV-infected ART naive patients in age
group 20–40 yrs was 1.81 ng/mL and in age group 40–60 yrs
was 1.95 ng/mL. The mean 8-OH-DG for HIV-infected in both
age groups (20–40 yrs and 40–60 yrs) on ART (ﬁrst line) were
2.50 ng/mL and 3.13 ng/mL, and (second line) 2.79 ng/mL and
3.27 ng/mL, respectively. ART accelerates DNA damage in HIV-
infected patients. These results show increased DNA damage
in HIV-infected patients on ART. In this study we  used linear
regression method to correlate protein carbonyl content with
DNA damage. We observed that increased protein carbonyl
content levels were positively associated with increased DNA
damage (OR: 0.356; 95% CI: 0.287–0.426 – p < 0.001). Increased
mean carbonyl content values were observed in HIV-infected
patients on ﬁrst line and second line ART of both age groups
(20–40 yrs and 40–60 yrs) than ART naive and negative con-
trols; similar pattern was observed with DNA damage marker
8-OH-DG in HIV-infected patients on ﬁrst line and second line
ART of both age groups (20–40 yrs and 40–60 yrs), as shown in
Table 1.
Discussion
Infection with the human immunodeﬁciency virus-1 (HIV) is
associated with clinical symptoms of accelerated aging, as
evidenced by increased incidence and diversity of age-related
illnesses at relatively young ages. Cardiovascular disease, dia-
betes, and several other conditions are more  prevalent at all
ages in those with HIV, suggesting there is an extra “hit” by
HIV and/or ART – that is, accentuated aging.4–7 There is con-
siderable evidence suggesting that oxidative stress plays a
critical role in both in vitro senescence and in vivo aging.23
Telomeres cap the ends of chromosomes and consist of hex-tent: a novel biomarker for aging in HIV/AIDS patients. Braz J Infect
americ TTAGGG repeats and the protective ‘shelterin’ protein
complex. Telomerase inhibition has been considered a possi-
ble mechanism by which ART in HIV/AIDS causes accelerated
aging.24
ARTICLE IN PRESSBJID-653; No. of Pages 7
 2 0 1 6
b
g
t
d
f
c
m
t
b
O
t
a
o
e
t
o
(
t
c
a
s
t
m
t
d
c
t
i
a
l
t
t
a
p
c
a
p
c
d
o
c
a
o
b
d
t
a
c
r
r
h
o
2
(
c
t
m
pb  r a z j i n f e c t d i s .
A very important marker of oxidative stress is protein car-
onylation, measured through estimating protein carbonyl
roups content in serum. Measuring protein carbonyl con-
ent is advantageous over other biomarkers of oxidative stress
ue to their early formation and detectable stability arising
rom protein side chains (Pro, Arg, Lys, and Thr).25 Protein
arbonylation is a type of protein oxidation that can be pro-
oted by reactive oxygen species. It usually refers to a process
hat forms reactive ketones or aldehydes that can be reacted
y 2,4-dinitrophenylhydrazine (DNPH) to form hydrazones.26
xidative modiﬁcation of proteins is known to affect pro-
ein function. Protein carbonyls and protein nitrotyrosine
re widely used and chemically stable biomarkers of protein
xidation. The protein carbonyls (PC) group are formed by
ither direct oxidation of certain amino acid residues, par-
icularly lysine, arginine, threonine, proline, and histidine
r secondarily reaction with product of lipid peroxidation
e.g., HNE) or glycoxidation reaction with lysine group.27 Pro-
ein carbonyls are better studied than protein nitration. The
oncentration of PC was stable, yielded quantitative results,
nd appeared to reﬂect disease endpoints in a biologically
igniﬁcant way. Carbonylated proteins are relatively difﬁcult
o induce compared with the SH oxidation of cysteine and
ethionine, and elevated levels of carbonylation are thought
o be a sign not only of oxidative stress, but also of disease-
erived protein dysfunction. Therefore, carbonylated proteins
an be used as oxidative stress biomarkers according to
heir special properties including irreversibility, unrepairabil-
ty, stability in physical condition and induction of protein
ggregation. Proteins are major bio-molecules that drive cel-
ular activities. Growing evidence suggests that onco-proteins,
umor suppressor proteins and oxidative stress-related pro-
eins play signiﬁcant roles in carcinogenesis.27 Aging is
ccompanied by accumulation of damaged DNA, misfolded
roteins, and oxidized proteins. A multitude of data indi-
ate that protein oxidation, accumulation of oxidized proteins,
nd protein aggregation as well as the impairment of the
roteosomal system play a major role in the aging pro-
ess and in the development of some, if not all, age-related
iseases.28
Free radicals may also bring about the oxidative damages
f DNA that are manifested by the development of various
omplications. The oxidatively induced DNA damage typically
ssociated with ROS are apurinic/apyrimidinic (AP) DNA sites,
xidized purines and pyrimidines, single strand and dou-
le strand DNA breaks. The accumulation of oxidative DNA
amage may be linked with age-associated neurodegenera-
ive disorders Alzheimer’s disease, Parkinson’s disease and
myotrophic lateral sclerosis. ROS generate 8-oxodG, which
an be used as an indicator of oxidative DNA damage in
elation to oxidative stress-driven diseases. Kryston et al.
eviewed the role of oxidative stress and DNA damage in
uman malignancies, and suggested the idea of using several
xidatively generated DNA lesions like 8-oxo-7,8-dihydro-
′-deoxyguanine (8-oxodG), also known as 8-hydroxydG
8-OHdG), thymine glycol, AP sites and oxidatively generatedPlease cite this article in press as: Kolgiri V, Patil VW. Protein carbonyl con
Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.007
lustered DNA lesions (OCDLs) as novel biomarkers of oxida-
ive stress.16 The most commonly used marker of oxidatively
odiﬁed DNA is 8-hydroxy-2′-deoxyguanosine (8-OHdG), a
roduct of oxidatively modiﬁed DNA base guanine. DNA can be;x  x x(x x):xxx–xxx 5
oxidized to produce many  oxidative products; however, oxida-
tion of the C-8 of guanine is one of the most common oxidative
events and results in a mutagenic lesion that produces
predominantly G-to-T transversion mutations. 8-OHdG was
found to be increased in a normal human LEC culture after
induced oxidative stress.17 Biological materials most often
used to measure levels of 8-OHdG include, serum, plasma,
urine and tissues. In recent years 8-hydroxydeoxyguanosine
(8-OHdG) has emerged as a marker of oxidative damage in the
patho-physiological processes of cancer.18,19 Levels of 8-OHdG
in various biological samples has been correlated with dis-
ease activity, thus 8-OHdG is a useful marker for study of DNA
damage caused by free radicals. There is ample circumstan-
tial evidence that oxidative stress leads to the accumulation of
DNA damage during aging.20 These data suggest that carbonyl
content and 8-OHdG levels are potentially useful biomarkers
of aging in HIV/AIDS patients. It will be important to account
for differential exposure to risk factors (e.g., smoking, alcohol,
non-HIV sexually transmitted diseases) between HIV-infected
and HIV-uninfected populations that are likely to result in
residual confounding when assessing associations of HIV with
increased risk of age-related illness. Therefore, we  have cho-
sen the subject population and control population with similar
economical background and similar confounders (smoking
and alcohol).
All experiments described in this study were performed
blindly with respect to subject status (ART naïve, ART ﬁrst-
line, ART second-line HIV patients, and control subjects).
In the present study the value of carbonyl content as gen-
eral marker of the inﬂammatory status was examined by
comparing carbonyl content levels to that of other recog-
nized biomarker of inﬂammation, i.e., DNA damage marker
8-OHdG. As seen in Fig. 1, the mean carbonyl content lev-
els were signiﬁcantly higher than that of the control group
for the ART-naïve patients (p < 0.001), those on ﬁrst-line ART
(p < 0.001), and those on second-line ART (p < 0.001). 8-OHdG
levels were also signiﬁcantly higher among ART naïve patients
(p = 0.001), those on ﬁrst-line ART (p < 0.001), and those on
second-line ART (p < 0.001) than those of the control group
(Fig. 2).
These results supported the notion of carbonyl content
as a better marker of inﬂammatory activity and are in line
with the concept of advanced HIV/AIDS as a condition with
increased inﬂammatory activity. Protein carbonyl content
and 8-OHdG levels are signiﬁcantly increased after ART in
HIV/AIDS patients of both age groups (Figs. 1 and 2). Sig-
niﬁcant increase in protein carbonyl content and 8-OHdG
levels were observed in HIV-infected patients in the age group
40–60 years when compared to those in the age group 20–40
years. In fact, protein carbonyl content levels show a strong
and signiﬁcant correlation with DNA damage. Thus we have
observed a close association between carbonyl content and
DNA damage in HIV/AIDS with ART (Fig. 3). This suggests
that the accumulation of carbonyl content may be an early
indication of increased DNA damage marker 8-OHdG levels
which may indicates accelerated aging in HIV/AIDS patientstent: a novel biomarker for aging in HIV/AIDS patients. Braz J Infect
on ART.
Inﬂammation and activation of coagulation pathways are
central to the pathophysiology leading to morbidity and
mortality in HIV-infected patients, as demonstrated by data
Please cite this article in press as: Kolgiri V, Patil VW. Protein carbonyl con
Dis. 2016. http://dx.doi.org/10.1016/j.bjid.2016.09.007
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Fig. 1 – Average carbonyl content among subjects.
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from the Strategies for Management of Antiretroviral Ther-
apy study, which showed that IL-6 and D-dimer were strongly
related to non-AIDS – deﬁning comorbidities and all-cause
mortality in patients on ART. In HIV infection, the heightened
inﬂammation and immune dysfunction related to accelerated
aging has stimulated assessment of several relevant biomark-
ers including C-reactive protein, IL-6, and D-dimer and their
associations with age-related morbidity and HIV infection.4
A weakness of the present study was that those biomarkers
could not included.
We  do not yet know if antioxidant therapy is use-
ful to prevent premature aging in HIV/AIDS patients. This
study demonstrated the extent of oxidative protein damage
and its association with DNA damage. Hence determina-
tion of protein carbonyl content can serve as a simpletent: a novel biomarker for aging in HIV/AIDS patients. Braz J Infect
biomarker for monitoring the magnitude of oxidative DNA
damage induced ART toxicity and/or accelerated aging in
HIV/AIDS patients. Further studies are needed to clarify this
issue.
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onclusion
his study in HIV/AIDS patients showed carbonyl content as a
etter indicator of the premature aging due to effect of ART. It
s clear that therapeutic side-effects and effects of HIV-1 infec-
ion together must be considered in the pathogenesis of aging
n the HIV/AIDS population, as antiretroviral therapy is linked
irectly to the infection. There is an abundance of evidence
mplicating ROS as one source of DNA damage associated with
ging, cancer, stress signaling, and other conditions. In the
resent study we  observed that carbonyl content is positively
orrelated to DNA damage marker 8-OHdG levels in HIV/AIDS
atients. Overall, our results demonstrate that the carbonyl
ontent may have a role as a biomarker for detecting oxidative
NA damage induced ART toxicity and/or accelerated aging in
IV/AIDS patients. Determination of carbonyl content is a very
imple and cost-effective method hence we suggest that car-
onyl content may be used as a biomarker for determination
f ART toxicity and/or premature aging in HIV/AIDS patients.
n future, management of premature aging and DNA damage
n HIV/AIDS patients should be prime concern for health care
hysicians.
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